文献速递食管与纵隔外科

I期食管腺癌手术时机对结局的影响

Effect of time to surgery on outcomes in stage I esophageal adenocarcinoma.
PubMed 文献 · J Thorac Cardiovasc Surg · 2019-10-08

基于美国国家癌症数据库2004-2015年2495例cT1N0M0食管腺癌患者,分析从诊断到食管切除术的时间与生存及病理升级的关系。按四分位分组时手术时机与生存无差异;作为连续变量,手术时间超过100天与更差生存和切缘阳性率增加相关。结论建议在安全前提下尽早行食管切除术。

要点

  • 手术时间超过100天与I期食管腺癌更差生存相关。
  • 手术时间超过100天与切缘阳性切除风险增加相关。
  • 按四分位分组未显示手术时机与生存的显著差异。

核心结论

  • 手术时间超过100天与I期食管腺癌患者更差结局相关,应尽早安全行食管切除术。

研究设计与样本

  • 回顾性队列研究,使用美国国家癌症数据库2004-2015年2495例cT1N0M0食管腺癌行食管切除术且未接受诱导治疗的患者。

主要发现

  • 按手术时间四分位分组,未调整和多变量分析均未显示组间生存差异。
  • 手术时间小于50天作为连续变量与生存改善相关(HR 0.99,95%CI 0.98-1.00)。
  • 手术时间大于100天与更差生存相关(HR 1.00,95%CI 1.00-1.01)和切缘阳性切除增加相关(OR 1.01,95%CI 1.00-1.02)。
  • 在高容量中心治疗、政府保险、诊断与治疗在不同中心与手术时间超过100天相关。

临床怎么用

  • 对I期食管腺癌患者,应在安全前提下尽早安排食管切除术,避免不必要的延迟超过100天。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

BACKGROUND: There are limited data on the safe interval from diagnosis to surgery in patients with stage I esophageal adenocarcinoma. We hypothesized that increased time to surgery would be associated with worse survival and increased nodal upstaging. METHODS: The National Cancer Database was used to identify patients with cT1N0M0 esophageal adenocarcinoma (2004-2015) who underwent esophagectomy without induction therapy. The primary outcome was survival, and the secondary outcomes were the rate of margin-positive resection and pathologic nodal upstaging. Time to surgery was modeled as a categoric variable, dividing patients into quartiles (Q1-4), and as a continuous variable using piecewise linear splines centered on 50 and 100 days. RESULTS: A total of 2495 patients met study criteria. When examined in quartiles, there was no difference in survival between groups based on time to surgery in both unadjusted and multivariable analyses. As a continuous variable, increasing time to surgery less than 50 days was associated with improved survival (hazard ratio, 0.99; 95% confidence interval, 0.98-1.00), and time to surgery greater than 100 days was associated with worse survival (hazard ratio, 1.00; 95% confidence interval, 1.00-1.01) and increased margin-positive resection (odds ratio, 1.01; 95% confidence interval, 1.00-1.02). Treatment at a high-volume center, government insurance, and diagnosis and treatment at different centers were associated with surgery beyond 100 days. CONCLUSIONS: Increasing time to surgery greater than 100 days is associated with worse outcomes in patients with stage I esophageal adenocarcinoma. In this patient population, esophagectomy should be offered as soon as safely possible.

来源:J Thorac Cardiovasc Surg,查看原文。版权归原作者所有。

引用

  1. Raman V, Jawitz OK, Voigt SL, et al. Effect of time to surgery on outcomes in stage I esophageal adenocarcinoma. J Thorac Cardiovasc Surg. 2019. PMID: 31740115. doi:10.1016/j.jtcvs.2019.09.123

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。